Kinetics of bradykinin levels during and after leucocyte filtration of platelet concentrates

Vox Sanguinis

Volumn 75, Issue 1, 1998, Pages 18-25

  Hild, M ^a   Soderstrom T ^a   Egberg, N ^a   Lundahl, Joachim ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3A; ENALAPRILAT; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD DONOR; CELL SEPARATION; CONTROLLED STUDY; FILTER; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LEUKOCYTE COUNT; NORMAL HUMAN; PRIORITY JOURNAL; SURFACE CHARGE; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIGENS, CD18; BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; BRADYKININ; COMPLEMENT C3A; ELECTROSTATICS; ENALAPRILAT; FILTRATION; HUMANS; KINETICS; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; MACROPHAGE-1 ANTIGEN; MIDDLE AGED; TIME FACTORS;

EID: 0031713147     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030953     Document Type: Article

References (34)

1. Liedén G, Hildén JO: Febrile transfusion reactions reduced by use of buffy-coat-poor erythrocyte concentrate. Vox Sang 1982;43:263-265.
2. Jensen Ls, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-845.
3. Saarinen UM, Kekomäki R, Siimes MA, Myllylä G: Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 1990;75:512-517.
4. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-3603.
5. Bontadini A, Fruet F, Tazzari PL, Lollini PL, Conte R: Comparative analysis of six different white cell-reduction filters for packed red cells. Transfusion 1994;34:531-535.
6. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME: Increased tumor necrosis factor alpha (TNF alpha), interleukin 1 and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-199.
7. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-628.
8. Snyder EL, Mechanic S, Baril L, Davenport R: Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter. Transfusion 1996;36:707-713.
9. Brand A: Positive and negative effects of transfused leukocytes; in Högman CF (ed): Leukocyte Depletion of Blood Components. Amsterdam. VU University Press, 1994, pp 11-17.
10. Bregman H, Daugirdas J, Ing T: Complication during hemodialysis; in Daugirdas J, Ing T (eds): Handbook of Dialysis, ed 2. Boston, Little, Brown, 1994, pp 149-168.
11. Dinarello CA: Interleukin-1: Its multiple biological effects and its associaton with hemodialysis. Blood Purif 1988;6:164-172.
12. Chenoweth DE, Cheung AK, Henderson L: Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 1983;24:764-769.
13. Verresen L, Waer M, Vanrenterghem Y, Michielsen P: Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 1990;336:1360-1362.
14. Olbricht CJ, Schaumann D, Fischer D: Anaphylactoid reactions, LDL apheresis with dextran sulphate and ACE inhibitors. Lancet 1992;340:908-909.
15. Davidson DC, Peart I, Turner S, Sangster M: Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis. Lancet 1994;343:1575.
16. Takahashi TA, Abe H, Hosoda M, Nakai K, Sekiguchi S: Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter (letter). Transfusion 1995;35:967.
17. Nielsen F, Damkjaer-Nielsen M, Rasmussen S, Kappelgaard AM, Giese J: Bradykinin in blood and plasma: Facts and fallacies. Acta Med Scand Suppl 1983:677:54-59.
18. Lundahl J, Halldén G, Hallgren M, Sköld CM, Hed J: Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures. J Immunol Meth 1995;180:93-100.
19. Colman RW, Scott CF, Brandwein H, Whitbread J: More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-rcduction filters (letter). Transfusion 1996:36:939-941.
20. Fried MR, Eastlund T, Christie B, Mullin GT, Key NS: Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. Transfusion 1996;36:900-903.
21. Sano H, Koga Y, Hamasaki K, Furuyama H, Itami N: Anaphylaxis associated with white-cell reduction filter. Lancet 1996;347:1053.
22. Gavras I: Bradykinin-mediated effect of ACE-inhibition. Kidney Int 1992:42:1020-1029.
23. Verresen L, Fink E, Lemke HD, Vanrenterghem Y: Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 1994;45:1497-1503.
24. Montdargent B, Toufik J, Carreno MP, Labarre D, Jozefowicz M: Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum, Biomaterials 1992;13:571-576.
25. Cheung A, Parker C, Wilcox L, Janatova J: Polyacrylonitrile binds more C3a than Cuprophane. Kidney Int 1990;37:1055-1059.
26. Thylén P, Fernvik E, Lundahl J, Hed J, Jacobson SH: Modulation of CD11b/CD18 on monocytes and granulocytes following hemodialysis membrane interaction in vitro. Int J Artif Organs 1996;19:156-163.
27. Thylén P, Lundahl J, Fernvik E, Hed J, Svensson SB, Jacobsson SH: Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992:12:393-400.
28. Takahashi TA, Abe H, Fujihara M, Nakai K, Hosoda M, Ohnishi Y, Sekiguchi S: Quality of platelet components: the role of suspension medium and leukocyte depletion. Transf Clin Biol 1995:6:481-487.
29. Catz SD, Sterin-Speziale NB: Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils. J Leukocyte Biol 1996;59:591-597.
30. Lundahl J, Hed J, Jacobson SH: Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion promoting glucoprotein Mac-1. Nephron 1992;61:163-169.
31. 558 and the adhesion molecule CD11b/CD18. Blood 1993;81:3122-3129.
32. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994,84:2068-2101.
33. Proud D: Kinin formation mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988;6:49-83.
34. Bonner G, Preis S, Schunk U, Toussaint C, Kaufmann W: Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 1990;15:S46-S56.